Successful use of HTF as a basal fertilization medium during SEcuRe mouse in vitro fertilization.

Assisted reproductive technologies Cryopreservation Genetic engineering In vitro fertilization Mouse models Sperm

Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
24 Aug 2023
Historique:
received: 09 03 2023
accepted: 08 08 2023
medline: 28 8 2023
pubmed: 25 8 2023
entrez: 24 8 2023
Statut: epublish

Résumé

The ever-increasing number of genetically engineered mouse models highlights the need for efficient archiving and distribution of these lines. Sperm cryopreservation has become the preferred technique for the majority of these models due to its low requirement of costs, time, and experimental animals. Yet, current in vitro fertilization (IVF) protocols either exhibit decreased fertilization efficiency for the most popular C57BL/6 strain, as recently demonstrated by us, or require costly and difficult-to-prepare media, respectively. As a result, we previously developed SEcuRe, a modified IVF protocol with low costs and high fertilization efficiency. The popular basal fertilization medium, Cook's Here we show that human tubal fluid (HTF), a popular and widely available medium with a known composition, can be used as a basal fertilization medium instead of RVF. Comparison of RVF and HTF during 58 independent SEcuRe IVFs with cryopreserved C57BL/6 sperm revealed equal fertilization and live birth rates. In addition, we demonstrate that HTF has a substantially extended shelf-life by utilizing commercial HTF that was six months past its expiration date, yet did not affect fertilization during IVF or subsequent embryo development. This finding not only increases the economic value of our modified method, but also validates it once more. Our results demonstrate that common, shelf-life extended HTF can be used in SEcuRe IVF in place of now-discontinued RVF medium and ensure the applicability of the method, which we since termed SEcuRe 2.0. Our modified SEcuRe 2.0 strategy will assist researchers to efficiently archive and distribute genetically engineered mouse models in a cost-effective, easily adaptable, and 3R-compliant manner with minimal animal use.

Identifiants

pubmed: 37620881
doi: 10.1186/s13104-023-06452-6
pii: 10.1186/s13104-023-06452-6
pmc: PMC10463834
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

184

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : KFO 329

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Tröder SE, Zevnik B. History of genome editing: from meganucleases to CRISPR. Lab Anim. 2021.
doi: 10.1177/0023677221994613 pubmed: 33622064
Hart-Johnson S, Mankelow K. Archiving genetically altered animals: a review of cryopreservation and recovery methods for genome edited animals. Lab Anim. 2021.
doi: 10.1177/00236772211007306 pubmed: 33847177
Behringer R, Gertsenstein M, Nagy KV, Nagy A. Manipulating the mouse embryo: a laboratory manual. 4th ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2014.
Takeo T, Sztein J, Nakagata N. The CARD method for mouse sperm cryopreservation and in vitro fertilization using frozen-thawed sperm. Methods Mol Biol. 2019;1874:243–56.
doi: 10.1007/978-1-4939-8831-0_14 pubmed: 30353518
Taft R. Mouse sperm cryopreservation using cryoprotectant containing monothioglycerol (MTG). Cold Spring Harbor protocols. 2017;2017(11):pdb.prot094490.
doi: 10.1101/pdb.prot094490 pubmed: 29093203
Taft R. In vitro fertilization in mice. Cold Spring Harbor Protoc. 2017;2017(11):pdb.prot094508.
doi: 10.1101/pdb.prot094508
Ostermeier GC, Wiles MV, Farley JS, Taft RA. Conserving, distributing and managing genetically modified mouse lines by sperm cryopreservation. PLoS ONE. 2008;3(7):e2792.
doi: 10.1371/journal.pone.0002792 pubmed: 18665210 pmcid: 2453316
Wigger M, Tröder SE, Zevnik B. A simple and economic protocol for efficient in vitro fertilization using cryopreserved mouse sperm. PLoS ONE. 2021;16(10):e0259202.
doi: 10.1371/journal.pone.0259202 pubmed: 34710162 pmcid: 8553151
Montoro-Gámez C, Nolte H, Molinié T, Evangelista G, Tröder S, Barth E, Popovic M, Trifunovic A, Zevnik B, Langer T, et al. SARM1 deletion delays cerebellar but not spinal cord degeneration in an enhanced mouse model of SPG7 deficiency. Brain. 2023. https://doi.org/10.1093/brain/awad136 .
doi: 10.1093/brain/awad136 pubmed: 37086482
Quinn P. Enhanced results in mouse and human embryo culture using a modified human tubal fluid medium lacking glucose and phosphate. J Assist Reprod Genet. 1995;12(2):97–105.
doi: 10.1007/BF02211377 pubmed: 7670281
Bath ML. Inhibition of in vitro fertilizing capacity of cryopreserved mouse sperm by factors released by damaged sperm, and stimulation by glutathione. PLoS ONE. 2010;5(2):e9387.
doi: 10.1371/journal.pone.0009387 pubmed: 20195370 pmcid: 2827551
Kito S, Hayao T, Noguchi-Kawasaki Y, Ohta Y, Hideki U, Tateno S. Improved in vitro fertilization and development by use of modified human tubal fluid and applicability of pronucleate embryos for cryopreservation by rapid freezing in inbred mice. Comp Med. 2004;54(5):564–70.
pubmed: 15575371
Low BE, Taft RA, Wiles MV. Mouse sperm cryopreservation and recovery of genetically modified mice. Methods Mol Biol. 2016;1438:55–66.
doi: 10.1007/978-1-4939-3661-8_3 pubmed: 27150083
Wigger M, Tröder SE, Zevnik B. A simple and economic protocol for efficient in vitro fertilization using cryopreserved mouse sperm. Protocols IO. 2021. https://doi.org/10.17504/protocols.io.bx2spqee .
doi: 10.17504/protocols.io.bx2spqee
Mähler M, Berard M, Feinstein R, Gallagher A, Illgen-Wilcke B, Pritchett-Corning K, Raspa M. FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units. Lab Anim. 2014;48(3):178–92.
doi: 10.1177/0023677213516312
du Sert NP, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410.
doi: 10.1371/journal.pbio.3000410
Russell WMS, Burch RL. The principles of humane experimental technique. London: Methuen; 1959.
Zevnik B, Jerchow B, Buch T. 3R measures in facilities for the production of genetically modified rodents. Lab Anim. 2022;51(6):162–77.
doi: 10.1038/s41684-022-00978-1

Auteurs

Magdalena Wigger (M)

Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany.
In Vivo Research Facility, Faculty of Medicine and University Hospital Cologne, University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany.

Marco Schneider (M)

Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany.
In Vivo Research Facility, Faculty of Medicine and University Hospital Cologne, University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany.

Anni Feldmann (A)

Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany.
In Vivo Research Facility, Faculty of Medicine and University Hospital Cologne, University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany.

Sonja Assenmacher (S)

Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany.
In Vivo Research Facility, Faculty of Medicine and University Hospital Cologne, University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany.

Branko Zevnik (B)

Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany.
In Vivo Research Facility, Faculty of Medicine and University Hospital Cologne, University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany.

Simon E Tröder (SE)

Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany. simon.troeder@uk-koeln.de.
In Vivo Research Facility, Faculty of Medicine and University Hospital Cologne, University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany. simon.troeder@uk-koeln.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH